Linnaeus Therapeutics, Inc.

CIK 1752026 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Linnaeus Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 2, 2026D/A0001752026-26-000007
Mar 31, 2026D/A0001752026-26-000006
Mar 13, 2026D/A0001752026-26-000005
Feb 27, 2026D0001752026-26-000004
Aug 22, 2025D0001752026-25-000001
Dec 26, 2024D/A0001752026-24-000002
Aug 12, 2024D0001752026-24-000001
Jan 26, 2023D0001752026-23-000001
Aug 24, 2021D0001752026-21-000003
Feb 8, 2019D0001752026-19-000001
Sep 7, 2018D0001752026-18-000001